Mark Gilbert, PhD, Leanne Picketts, MEd, Anna MacLeod, PhD, and Wendy A. Stewart, MD, MMEd, PhD
This study offers an arts-based tool set capable of being delivered within the familiar medical education setting and established structure of the OSCE.
AMA J Ethics. 2022;24(7):E556-562. doi:
10.1001/amajethics.2022.556.
Sophia Miao, MD and Wendy A. Stewart, MD, MMEd, PhD
This pilot study used phenomenology combined with quantitative measures of self-esteem and self-efficacy to explore influences of storytelling through lyrical and musical composition on youth self-concept.
AMA J Ethics. 2022;24(7):E576-583. doi:
10.1001/amajethics.2022.576.
Miranda B. Olson, MSc, Stacey Springs, PhD, and Jay Baruch, MD
Responsible arts in health research requires interrogating what counts as evidence, especially when the insistence on rigor risks oversimplifying and diminishing what’s ineffable about the arts.
AMA J Ethics. 2022;24(7):E617-621. doi:
10.1001/amajethics.2022.617.
Professor Katie Watson joins Ethics Talk to discuss what clinicians need to know about changes to the post-June 2022 legal, ethical, and clinical landscape of abortion care in the US.
Professor Michele Bratcher Goodwin joins Ethics Talk to consider how members of different US Supreme Courts have interpreted the US Constitution in ways that have supported or undermined liberty in surprising ways.
Professor Katie Watson joins Ethics Talk to consider key questions about clinical and legal risk management for clinicians trying keep patients safe and for patients with complex pregnancies trying to stay alive.
Artist and researcher Dr Mark Gilbert joins Ethics Talk to discuss arts-based research: what it is, who it’s for, and why we should pay closer attention to it as a method of clinical inquiry.
Rebekah Davis Reed, PhD, JD and Erik L. Antonsen, PhD, MD
Though the National Aeronautics and Space Administration’s collection of disaggregated genetic data for occupational surveillance and research raises numerous privacy concerns, the Genetic Information Nondiscrimination Act of 2008 allows genetic information to be used to develop personal pharmaceuticals.
AMA J Ethics. 2018;20(9):E849-856. doi:
10.1001/amajethics.2018.849.